Intravenous phosphate loading increases fibroblast growth factor 23 in uremic rats

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Arai Nunota, Noriko ^a   Mizobuchi, Masahide ^a   Ogata, Hiroaki ^b   Yamazaki Nakazawa, Ai ^a   Kumata, Chiaki ^b   Kondo, Fumiko ^a   Hosaka, Nozomu ^a   Koiwa, Fumihiko ^c   Kinugasa, Eriko ^b   Shibata, Takanori ^a   Akizawa, Tadao ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY NORTHERN YOKOHAMA HOSPITAL   (Japan)

^c SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; OXIDOREDUCTASE; OXYGENASE; PHOSPHATE; SODIUM PHOSPHATE COTRANSPORTER 2A; STEROID 24 HYDROXYLASE; UNCLASSIFIED DRUG; COLECALCIFEROL 24 HYDROXYLASE; FGF23 PROTEIN, RAT; FIBROBLAST GROWTH FACTOR; SLC34A1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; KIDNEY FUNCTION; KIDNEY INJURY; MALE; NONHUMAN; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PROTEIN EXPRESSION; RAT; UREMIA; URINALYSIS; ANIMAL; BLOOD; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; NEPHRECTOMY; SPRAGUE DAWLEY RAT;

ANIMALS; FIBROBLAST GROWTH FACTORS; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; MALE; NEPHRECTOMY; PHOSPHATES; RATS; RATS, SPRAGUE-DAWLEY; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIA; UREMIA; VITAMIN D3 24-HYDROXYLASE;

EID: 84898734741     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091096     Document Type: Article

References (33)

1. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, et al. (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218. (Pubitemid 39031360)
2. Voormolen N, Noordzij M, Grootendorst DC, Beetz I, Sijpkens YW, et al. (2007) High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 22: 2909-2916. (Pubitemid 350093423)
3. Martin A, David V, Quarles LD (2012) Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev 92: 131-155.
4. Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, et al. (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16: 2205-2215. (Pubitemid 41716454)
5. Wolf M (2010) Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol 21: 1427-1435.
6. Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, et al. (2007) Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 18: 2600-2608.
7. Hsu HJ, Wu MS (2009) Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients. Am J Med Sci 337: 116-122.
8. Jean G, Bresson E, Terrat JC, Vanel T, Hurot JM, et al. (2009) Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant 24: 948-955.
9. Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, et al. (2010) FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int 78: 679-685.
10. Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, et al. (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359: 584-592.
11. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, et al. (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121: 4393-4408.
12. Perwad F, Azam N, Zhang MY, Yamashita T, Tenenhouse HS, et al. (2005) Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology 146: 5358-5364. (Pubitemid 41653049)
13. Ferrari SL, Bonjour JP, Rizzoli R (2005) Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90: 1519-1524. (Pubitemid 40464013)
14. Vervloet MG, van Ittersum FJ, Buttler RM, Heijboer AC, Blankenstein MA, et al. (2011) Effects of dietary phosphate and calcium intake on fibroblast growth factor-23. Clin J Am Soc Nephrol 6: 383-389.
15. Liu S, Tang W, Zhou J, Stubbs JR, Luo Q, et al. (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17: 1305-1315. (Pubitemid 43673410)
16. Kawata T, Imanishi Y, Kobayashi K, Miki T, Arnold A, et al. (2007) Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. J Am Soc Nephrol 18: 2683-2688. (Pubitemid 47531195)
17. Lavi-Moshayoff V, Wasserman G, Meir T, Silver J, Naveh-Many T (2010) PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol 299: F882-889.
18. Krieger NS, Culbertson CD, Kyker-Snowman K, Bushinsky DA (2012) Metabolic acidosis increases fibroblast growth factor 23 in neonatal mouse bone. Am J Physiol Renal Physiol 303: F431-436.
19. Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB (2003) Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64: 2272-2279. (Pubitemid 37449564)
20. Nishida Y, Taketani Y, Yamanaka-Okumura H, Imamura F, Taniguchi A, et al. (2006) Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int 70: 2141-2147. (Pubitemid 44871378)
21. Saji F, Shigematsu T, Sakaguchi T, Ohya M, Orita H, et al. (2010) Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH. Am J Physiol Renal Physiol 299: F1212-1217.
22. Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, et al. (2005) Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280: 2543-2549. (Pubitemid 40189356)
23. Antoniucci DM, Yamashita T, Portale AA (2006) Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 91: 3144-3149. (Pubitemid 44271770)
24. Shimada T, Yamazaki Y, Takahashi M, Hasegawa H, Urakawa I, et al. (2005) Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. Am J Physiol Renal Physiol 289: F1088-1095. (Pubitemid 41447065)
25. Nagano N, Miyata S, Abe M, Kobayashi N, Wakita S, et al. (2006) Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Kidney Int 69: 531-537. (Pubitemid 43164446)
26. Quarles LD (2008) Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 118: 3820-3828.
27. Cancela AL, Oliveira RB, Graciolli FG, dos Reis LM, Barreto F, et al. (2011) Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate. Nephron Clin Pract 117: c74-82.
28. Hughes MR, Brumbaugh PF, Hussler MR, Wergedal JE, Baylink DJ (1975) Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat. Science 190: 578-580.
29. Sato T, Tominaga Y, Ueki T, Goto N, Matsuoka S, et al. (2004) Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism. Am J Kidney Dis 44: 481-487. (Pubitemid 39164625)
30. Imanishi Y, Inaba M, Nakatsuka K, Nagasue K, Okuno S, et al. (2004) FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 65: 1943-1946. (Pubitemid 38591047)
31. Hasegawa H, Nagano N, Urakawa I, Yamazaki Y, Iijima K, et al. (2010) Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int 78: 975-980.
32. Berndt T, Thomas LF, Craig TA, Sommer S, Li X, et al. (2007) Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc Natl Acad Sci U S A 104: 11085-11090. (Pubitemid 47175230)
33. Quarles LD (2013) A systems biology preview of the relationships between mineral and metabolic complications in chronic kidney disease. Semin Nephrol 33: 130-142.